Intentional delivery versus expectant management with preterm ruptured membranes at 30–34 weeks' gestation

Obstetrics and Gynecology

Volumn 86, Issue 6, 1995, Pages 875-879

  Cox, Susan M ^a   Leveno, Kenneth J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CESAREAN SECTION; CHORIOAMNIONITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DYSTOCIA; FEMALE; FETUS DISTRESS; FETUS OUTCOME; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; MALPRESENTATION; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; DELIVERY, OBSTETRIC; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD;

EID: 0029431292     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(95)00303-9     Document Type: Article

References (23)

1. Premature rupture of the membranes
2. Premature rupture of the membranes: The enigma of the obstetrician
3. Conservative management of patients with premature rupture of fetal membranes
4. Management of preterm premature rupture of membranes: Lack of a national consensus
5. Expectant management of preterm ruptured membranes: Effects of antimicrobial therapy
6. Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture
7. Antibiotic therapy in preterm premature rupture of membranes: A randomized prospective, double-blind trial
8. Antimicrobial therapy in preterm premature rupture of membranes: Results of a prospective double-blind, placebo-controlled trial of erythromycin
9. A case control study of chorioamnionic infection and histologic chorioamnionitis in prematurity
10. Birth weight threshold for postponing preterm birth
11. The natural history of preterm ruptured membranes; What to expect of expectant management
12. Expectant management of preterm premature rupture of the membranes
13. Group B streptococcal infections in pregnancy
14. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis
15. Adverse perinatal outcome and resistant Enterobacteriaeceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage
16. Clinical obstetrics (editorial)
17. Intrapartum chemoprophylaxis of perinatal group B streptococcal infections: A critical review of randomized controlled trials
18. Group B streptococcus: The US controversy
19. Prevention of group B streptococcal disease: A public health perspective
20. Premature rupture of membranes: A prospective, randomized evaluation of steroids, latent phase, and expectant management
21. Preterm premature rupture of the membranes with fetal pulmonary maturity present: A prospective study
22. Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: A randomized trial